Repeat Cytology and Human Papillomavirus Screening Strategies in Detecting Preinvasive Cervical Lesions

被引:4
作者
Li, Kemin [1 ]
Yin, Rutie [1 ]
机构
[1] Sichuan Univ, West China Univ Hosp 2, Dept Gynaecol, Chengdu 610064, Sichuan, Peoples R China
关键词
RANDOMIZED-TRIAL; WOMEN; NEOPLASIA; ABNORMALITIES; PERSISTENCE; INFECTION;
D O I
10.1097/MD.0000000000000435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to determine the value of human papillomavirus (HPV) testing in screening patients with pre-invasive cervical lesions. Seven hundred thirty-four women diagnosed with atypical squamous cells of undetermined significance (ASCUS+) cervical cytology during routine screening had additional cytologic testing and HPV DNA testing within 6 months of their diagnosis, after which all women who tested positive were referred for colposcopy and biopsy. The test findings were then used to determine the screening value of HPV for diagnosing preinvasive cervical lesions. Cytology and HPV testing were compared by conventional cytology. The odds ratio (OR) of sensitivity usingASCUS+or low-grade squamous intraepithelial neoplasia (LSIL+) as a cutoff for detecting cervical intraepithelial neoplasia (CIN) II+ was, respectively, 0.78 (0.72, 0.85) and 0.82 (0.70, 0.95) (P < 0.01). The cytology for triage and conventional cytology had different sensitivities usingASCUS+ orLSIL+ as the cutoff (P < 0.01). The cytology or HPV testing and conventional cytology had a difference in sensitivity usingASCUS+, LSIL+, or high-grade squamous intraepithelial neoplasia (HSIL+) as the cutoff (P < 0.01). Cytology and HPV testing were also compared with conventional cytology. The OR of specificity usingASCUS+ orLSIL+ as the cutoff for the detection of CIN II+ was 1.97 (1.68, 2.31) and 1.10 (1.02, 1.18), respectively (P < 0.01). The cytology for triage and conventional cytology had a difference in specificity when ASCUS+ or LSIL+ was used as the cutoff (P < 0.01). Finally, the cytology or HPV testing and conventional cytology had a difference in specificity when ASCUS+, LSIL+, orHSIL+ was used as the cutoff (P < 0.01). Cytology and HPV testing and cytology for triage improved the specificity of detecting CIN II+, but this did not improve the sensitivity. Additionally, cytology or HPV testing improved the sensitivity of detecting CIN II+ but not the specificity.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] DNA ploidy measurement and human papillomavirus in abnormal cervical cytology
    Costa, Ane Francyne
    Pogere, Adriane
    Beltrame Farina Pasinato, Ana Paula
    Monteiro Bello, Edson Jose
    Casimiro Onofre, Alexandre Sherlley
    de Miranda Onofre, Fabiana Botelho
    CYTOPATHOLOGY, 2021, 32 (02) : 180 - 186
  • [42] Human Papillomavirus Testing in Cervical Cancer Screening
    Castle, Philip E.
    Cremer, Miriam
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2013, 40 (02) : 377 - +
  • [43] Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
    Huh, Warner K.
    Williams, Erin
    Huang, Joice
    Bramley, Tommy
    Poulios, Nick
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2015, 13 (01) : 95 - 107
  • [44] Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era
    Tota, Joseph
    Mahmud, Salaheddin M.
    Ferenczy, Alex
    Coutlee, Francois
    Franco, Eduardo L.
    SEXUAL HEALTH, 2010, 7 (03) : 376 - 382
  • [45] A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines
    Guerrero, Anna Melissa
    Genuino, Anne Julienne
    Santillan, Melanie
    Praditsitthikorn, Naiyana
    Chantarastapornchit, Varit
    Teerawattananon, Yot
    Alejandria, Marissa
    Toral, Jean Anne
    BMC PUBLIC HEALTH, 2015, 15
  • [46] Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
    Nygard, Mari
    Hansen, Bo T.
    Kjaer, Susanne K.
    Hortlund, Maria
    Tryggvadottir, Laufey
    Munk, Christian
    Lagheden, Camilla
    Sigurdardottir, Lara G.
    Campbell, Suzanne
    Liaw, Kai-Li
    Dillner, Joakim
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (04) : 972 - 981
  • [47] Meta-Analysis of Type-Specific Human Papillomavirus Prevalence in Iranian Women With Normal Cytology, Precancerous Cervical Lesions and Invasive Cervical Cancer: Implications For Screening and Vaccination
    Jalilvand, Somayeh
    Shoja, Zabihollah
    Nourijelyani, Keramat
    Tohidi, Hamid Reza
    Hamkar, Rasool
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (02) : 287 - 295
  • [48] Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs
    Kantathavorn, Nuttavut
    Mahidol, Chulabhorn
    Sritana, Narongrit
    Sricharunrat, Thaniya
    Phoolcharoen, Natacha
    Auewarakul, Chirayu
    Teerayathanakul, Narongchai
    Taepisitpong, Chantanee
    Saeloo, Siriporn
    Sornsamdang, Gaidganok
    Udomchaiprasertkul, Wandee
    Krongthong, Waraphorn
    Arnamwong, Arpaporn
    INFECTIOUS AGENTS AND CANCER, 2015, 10
  • [49] Age-specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross-sectional study
    Bao, Heling
    Ma, Lan
    Zhao, Yanxia
    Song, Bo
    Di, Jiangli
    Wang, Linhong
    Gao, Yanqiu
    Ren, Wenhui
    Wang, Shi
    Wu, Jiuling
    Wang, Hai-Jun
    CANCER COMMUNICATIONS, 2022, 42 (03) : 191 - 204
  • [50] Modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions
    Schlecht, NF
    Platt, RW
    Negassa, A
    Duarte-Franco, E
    Rohan, TE
    Ferenczy, A
    Villa, LL
    Franco, EL
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (09) : 878 - 886